Maternal immunization, a pivotal component of prenatal care, stands as a beacon of protection for both expectant mothers and their newborns. This innovative medical intervention involves administering vaccines to pregnant individuals, leveraging the unique window of opportunity during pregnancy to confer immunity against infectious diseases. The rationale behind maternal immunization is twofold – safeguarding the health of the pregnant person and providing passive immunity to the developing fetus, offering protection during the vulnerable early months of life. Vaccines administered during pregnancy are carefully selected based on the potential risks posed by specific infections and the proven safety and efficacy of the vaccines. One of the most notable examples of maternal immunization is the influenza vaccine. Pregnant individuals are particularly susceptible to severe complications from influenza, and maternal immunization not only shields the expectant mother but also confers protection to the newborn during the first few months of life. Similarly, maternal immunization against tetanus, diphtheria, and pertussis (Tdap) is a standard recommendation, as pertussis can be particularly severe in infants. The administration of the Tdap vaccine during pregnancy ensures that newborns receive a boost of protective antibodies through transplacental transfer.
The field of maternal immunization is dynamic, with ongoing research exploring the potential to protect against a broader spectrum of infections. Advances in vaccine development, safety assessments, and the understanding of maternal and fetal immune responses contribute to the expansion of the immunization landscape. The symposium on Maternal Immunization at this gynecology event serves as a forum for experts to share insights, discuss the latest research findings, and explore ways to optimize maternal vaccination strategies. Beyond individual protection, maternal immunization holds the promise of impacting community health by reducing the incidence of infections in vulnerable populations. The concept of herd immunity, wherein a significant portion of the population is immunized, indirectly protects those who are not vaccinated, including newborns who are too young to receive certain vaccines. Maternal immunization exemplifies the interconnectedness of public health and underscores the importance of a comprehensive approach to safeguarding maternal and infant well-being.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia